Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Felix J F Herth, Robert A Sandhaus, Alice M Turner, Maria Sucena, Tobias Welte & Timm Greulich. (2021) Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2983-2996.
Read now
Read now
Priya S Chukowry, Ross Gareth Edgar & Alice M Turner. (2019) Alpha 1 antitrypsin deficiency: a rare multisystem disease, predominantly affecting the lung. Expert Opinion on Orphan Drugs 7:7-8, pages 315-326.
Read now
Read now
Kenneth R Chapman, Joanna Chorostowska-Wynimko, A Rembert Koczulla, Ilaria Ferrarotti & Noel G McElvaney. (2018) Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 419-432.
Read now
Read now
Alan F Barker, Michael A Campos, Mark L Brantly, James M Stocks, Robert A Sandhaus, Douglas Lee, Kimberly Steinmann, Jiang Lin & Susan Sorrells. (2017) Bioequivalence of a Liquid Formulation of Alpha1-Proteinase Inhibitor Compared with Prolastin®-C (Lyophilized Alpha1-PI) in Alpha1-Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:6, pages 590-596.
Read now
Read now
Ross G Edgar, Mitesh Patel, Susan Bayliss, Diana Crossley, Elizabeth Sapey & Alice M Turner. (2017) Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1295-1308.
Read now
Read now
Maria Paula Henao & Timothy J. Craig. (2016) Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency. Expert Review of Respiratory Medicine 10:12, pages 1281-1294.
Read now
Read now
Reena Berman, Di Jiang, Qun Wu & Hong Wei Chu. (2016) α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1279-1286.
Read now
Read now
Antonio Anzueto. (2015) Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease: A Family Perspective. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:4, pages 462-467.
Read now
Read now
Articles from other publishers (37)
Zhaoyang Li, Mitali Gaurav & Leman Yel. (2023) Evaluation of body weight–based dosing, alternative dosing regimens, and treatment interruptions for α1-proteinase inhibitors and implications on biochemical efficacy in patients with α1-antitrypsin deficiency. Pulmonary Pharmacology & Therapeutics 83, pages 102265.
Crossref
Crossref
Kuniaki Seyama, Masaru Suzuki, Sadatomo Tasaka, Toshihiro Nukiwa, Tadashi Sato, Satoshi Konno, Susan Sorrells, Junliang Chen, Maria Esperança Aragonés & Hitoshi Minamino. (2022) Long-term safety of Prolastin®-C, an alpha1-proteinase inhibitor, in Japanese patients with alpha1-antitrypsin deficiency. Respiratory Investigation 60:6, pages 831-839.
Crossref
Crossref
J.-F. Mornex, M. Balduyck, M. Bouchecareilh, A. Cuvelier, R. Epaud, M. Kerjouan, O. Le Rouzic, C. Pison, L. Plantier, M.-C. Pujazon, M. Reynaud-Gaubert, A. Toutain, B. Trumbic, M.-C. Willemin, M. Zysman, O. Brun, M. Campana, F. Chabot, V. Chamouard, M. Dechomet, J. Fauve, B. Girerd, C. Gnakamene, S. Lefrançois, J.-N. Lombard, B. Maitre, C. Maynié-François, A. Moerman, A. Payancé, P. Reix, D. Revel, M.-P. Revel, M. Schuers, P. Terrioux, D. Theron, F. Willersinn, V. Cottin & H. Mal. (2022) Atteinte pulmonaire du déficit en alpha-1 antitrypsine. Recommandations pratiques pour le diagnostic et la prise en charge. Revue des Maladies Respiratoires 39:7, pages 633-656.
Crossref
Crossref
Izel Koyuturk, Surbhi Kedia, Anna Robotham, Alexandra Star, Denis Brochu, Janelle Sauvageau, John Kelly, Michel Gilbert & Yves Durocher. (2022) High‐level production of wild‐type and oxidation‐resistant recombinant alpha‐1‐antitrypsin in glycoengineered CHO cells. Biotechnology and Bioengineering 119:9, pages 2331-2344.
Crossref
Crossref
Lukas Wettstein, Frank Kirchhoff & Jan Münch. (2022) The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment. International Journal of Molecular Sciences 23:3, pages 1351.
Crossref
Crossref
Martina Oriano, Francesco Amati, Andrea Gramegna, Anthony De Soyza, Marco Mantero, Oriol Sibila, Sanjay H. Chotirmall, Antonio Voza, Paola Marchisio, Francesco Blasi & Stefano Aliberti. (2021) Protease–Antiprotease Imbalance in Bronchiectasis. International Journal of Molecular Sciences 22:11, pages 5996.
Crossref
Crossref
Lukas Wettstein, Tatjana Weil, Carina Conzelmann, Janis A. Müller, Rüdiger Groß, Maximilian Hirschenberger, Alina Seidel, Susanne Klute, Fabian Zech, Caterina Prelli Bozzo, Nico Preising, Giorgio Fois, Robin Lochbaum, Philip Maximilian Knaff, Volker Mailänder, Ludger Ständker, Dietmar Rudolf Thal, Christian Schumann, Steffen Stenger, Alexander Kleger, Günter Lochnit, Benjamin Mayer, Yasser B. Ruiz-Blanco, Markus Hoffmann, Konstantin M. J. Sparrer, Stefan Pöhlmann, Elsa Sanchez-Garcia, Frank Kirchhoff, Manfred Frick & Jan Münch. (2021) Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nature Communications 12:1.
Crossref
Crossref
Khushboo Goel, Charlie Strange, Robert A Sandhaus, Irina Petrache & Karina A Serban. (2021) Updates in the Management of Alpha-1 Antitrypsin Deficiency Lung Disease. US Respiratory & Pulmonary Diseases 6:1, pages 26.
Crossref
Crossref
Igor Barjaktarevic & Michael Campos. (2021) Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know. Therapeutic Advances in Chronic Disease 12_suppl, pages 204062232110101.
Crossref
Crossref
Roxana Cortes-Lopez & Igor Barjaktarevic. (2020) Alpha-1 Antitrypsin Deficiency: a Rare Disease?. Current Allergy and Asthma Reports 20:9.
Crossref
Crossref
José Luis López-Campos, Laura Carrasco Hernandez & Candelaria Caballero Eraso. (2020) Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy. Journal of Clinical Medicine 9:8, pages 2526.
Crossref
Crossref
Benjamin M. Scott & William P. Sheffield. (2019)
Engineering the serpin α
1
‐antitrypsin: A diversity of goals and techniques
. Protein Science 29:4, pages 856-871.
Crossref
Crossref
Trevor Cickovski, Astrid Manuel, Kalai Mathee, Michael Campos & Giri Narasimhan. 2020. Computational Advances in Bio and Medical Sciences. Computational Advances in Bio and Medical Sciences
90
101
.
Diana Crossley, Robert Stockley & Elizabeth Sapey. (2019) Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?. Drugs & Aging 36:9, pages 823-840.
Crossref
Crossref
Irina Petrache. (2019) Is More Better? Promising Biological Effects of Double-Dose Alpha 1-Antitrypsin Therapy. American Journal of Respiratory and Critical Care Medicine 200:3, pages 270-272.
Crossref
Crossref
Michael A. Campos, Patrick Geraghty, Gregory Holt, Eliana Mendes, Paul R. Newby, Shuren Ma, Landy V. Luna-Diaz, Gerard M. Turino & Robert A. Stockley. (2019) The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial. American Journal of Respiratory and Critical Care Medicine 200:3, pages 318-326.
Crossref
Crossref
Kuniaki Seyama, Toshihiro Nukiwa, Tadashi Sato, Masaru Suzuki, Satoshi Konno, Kazuhisa Takahashi, Masaharu Nishimura, Kimberly Steinmann, Susan Sorrells, Junliang Chen & Ken-ichi Hayashi. (2019) Safety and pharmacokinetics of Alpha-1 MP (Prolastin®-C) in Japanese patients with alpha1-antitrypsin (AAT) deficiency. Respiratory Investigation 57:1, pages 89-96.
Crossref
Crossref
Timm Greulich, Jan Chlumsky, Marion Wencker, Oliver Vit, Michael Fries, Thomas Chung, Amgad Shebl, Claus Vogelmeier, Kenneth R. Chapman & Noel G. McElvaney. (2018)
Safety of biweekly α
1
-antitrypsin treatment in the RAPID programme
. European Respiratory Journal 52:5, pages 1800897.
Crossref
Crossref
Timothy J. Craig & Maria Paula Henao. (2018)
Advances in managing COPD related to α
1
-antitrypsin deficiency: An under-recognized genetic disorder
. Allergy 73:11, pages 2110-2121.
Crossref
Crossref
Pius Ochieng, Sridesh Nath, Reane Macarulay, Edward Eden, Abdoulaye Dabo, Michael Campos, Xian-Cheng Jiang, Robert F. Foronjy & Patrick Geraghty. (2018) Phospholipid transfer protein and alpha-1 antitrypsin regulate Hck kinase activity during neutrophil degranulation. Scientific Reports 8:1.
Crossref
Crossref
Article Editorial. (2018) Diagnosis and treatment of pulmonarydisease in α1-antitrypsin deficiency: a statement of European Respiratory Society. Russian Pulmonology 28:3, pages 273-295.
Crossref
Crossref
Haitham S. Al Ashry & Charlie Strange. (2017) COPD in individuals with the PiMZ alpha-1 antitrypsin genotype. European Respiratory Review 26:146, pages 170068.
Crossref
Crossref
Marc Miravitlles, Asger Dirksen, Ilaria Ferrarotti, Vladimir Koblizek, Peter Lange, Ravi Mahadeva, Noel G. McElvaney, David Parr, Eeva Piitulainen, Nicolas Roche, Jan Stolk, Gabriel Thabut, Alice Turner, Claus Vogelmeier & Robert A. Stockley. (2017)
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α
1
-antitrypsin deficiency
. European Respiratory Journal 50:5, pages 1700610.
Crossref
Crossref
Michael A. Tortorici, James A. Rogers, Oliver Vit, Martin Bexon, Robert A. Sandhaus, Jonathan Burdon, Joanna Chorostowska-Wynimko, Philip Thompson, James Stocks, Noel G. McElvaney, Kenneth R. Chapman & Jonathan M. Edelman. (2017) Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency. British Journal of Clinical Pharmacology 83:11, pages 2386-2397.
Crossref
Crossref
Adolfo G. Mauro, Eleonora Mezzaroma, Carlo Marchetti, Pratyush Narayan, Marco G. Del Buono, Marialessia Capuano, Andrea Prestamburgo, Simone Catapano, Fadi N. Salloum, Antonio Abbate & Stefano Toldo. (2017) A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction. Journal of Cardiovascular Pharmacology 69:5, pages 273-278.
Crossref
Crossref
Ignacio Blanco. 2017. Blanco's Overview of Alpha-1 Antitrypsin Deficiency. Blanco's Overview of Alpha-1 Antitrypsin Deficiency
207
225
.
Michael Campos & Jorge Lascano. 2017. Alpha-1 Antitrypsin Deficiency. Alpha-1 Antitrypsin Deficiency
249
262
.
Li Zuo, Benjamin K. Pannell, Tingyang Zhou & Chia-Chen Chuang. (2016) Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications. Gene 589:2, pages 118-122.
Crossref
Crossref
Umur Hatipoğlu & James K. Stoller. (2016) α1-Antitrypsin Deficiency. Clinics in Chest Medicine 37:3, pages 487-504.
Crossref
Crossref
Kenneth R Chapman, Jonathan G W Burdon, Eeva Piitulainen, Robert A Sandhaus, Niels Seersholm, James M Stocks, Berend C Stoel, Liping Huang, Zhenling Yao, Jonathan M Edelman & Noel G McElvaney. (2015) Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. The Lancet 386:9991, pages 360-368.
Crossref
Crossref
Susan Sorrells, Sandra Camprubi, Rhonda Griffin, Junliang Chen & Jaume Ayguasanosa. (2015) SPARTA clinical trial design: Exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency. Respiratory Medicine 109:4, pages 490-499.
Crossref
Crossref
Francisco Casas, Ignacio Blanco, María Teresa Martínez, Ana Bustamante, Marc Miravitlles, Sergio Cadenas, José M. Hernández, Lourdes Lázaro, Esther Rodríguez, Francisco Rodríguez-Frías, María Torres & Beatriz Lara. (2015) Actualización sobre indicaciones de búsqueda activa de casos y tratamiento con alfa-1 antitripsina por vía intravenosa en pacientes con enfermedad pulmonar obstructiva crónica asociada a déficit de alfa-1 antitripsina. Archivos de Bronconeumología 51:4, pages 185-192.
Crossref
Crossref
Francisco Casas, Ignacio Blanco, María Teresa Martínez, Ana Bustamante, Marc Miravitlles, Sergio Cadenas, José M. Hernández, Lourdes Lázaro, Esther Rodríguez, Francisco Rodríguez-Frías, María Torres & Beatriz Lara. (2015) Indications for Active Case Searches and Intravenous Alpha-1 Antitrypsin Treatment for Patients With Alpha-1 Antitrypsin Deficiency Chronic Pulmonary Obstructive Disease: An Update. Archivos de Bronconeumología (English Edition) 51:4, pages 185-192.
Crossref
Crossref
Dieter E. Jenne. (2014)
Off-Target Rewards of Augmentation Therapy with α
1
-Antitrypsin
. American Journal of Respiratory and Critical Care Medicine 190:11, pages 1203-1204.
Crossref
Crossref
Patrick Geraghty, Edward Eden, Manju Pillai, Michael Campos, Noel G. McElvaney & Robert F. Foronjy. (2014)
α
1
-Antitrypsin Activates Protein Phosphatase 2A to Counter Lung Inflammatory Responses
. American Journal of Respiratory and Critical Care Medicine 190:11, pages 1229-1242.
Crossref
Crossref
Michael A. Campos & Jorge Lascano. (2014) α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy. Therapeutic Advances in Respiratory Disease 8:5, pages 150-161.
Crossref
Crossref
S. Ottaviani, M. Gorrini, I. Ferrarotti & M. Luisetti. (2014) Inherited alpha1-antitrypsin deficiency: Is the level the key message?. Revue des Maladies Respiratoires 31:8, pages 687-690.
Crossref
Crossref